A Prospective, Randomized, Double-Blind, Placebo-Controlled Study of the Effectiveness and Safety of Risperidal CONSTA Augmentation in Adult Patients With Frequently-Relapsing Bipolar Disorder

Trial Profile

A Prospective, Randomized, Double-Blind, Placebo-Controlled Study of the Effectiveness and Safety of Risperidal CONSTA Augmentation in Adult Patients With Frequently-Relapsing Bipolar Disorder

Completed
Phase of Trial: Phase III

Latest Information Update: 03 May 2010

At a glance

  • Drugs Risperidone (Primary)
  • Indications Bipolar disorders; Bipolar I disorders
  • Focus Registrational; Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 01 Jan 2010 Results were reported in Bipolar Disorders.
    • 03 Sep 2008 Results were presented at ECNP 2008.
    • 17 Jul 2008 Results have been presented at the 26th Collegium Internationale Neuro Psychopharmacologicum Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top